|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.03 USD | +4.93% |
|
-3.83% | -37.34% |
| 15/05 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
| 14/05 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
Adherex Technologies Inc. announced that David Lieberman has resigned from the board of directors. Rosty Raykov, CEO and a director of the company, will assume the role of Chairman of the board of sirectors. Robert Andrade has resigned as Chief Financial Officer and a director of the company.
Krysia Lynes, who has accounting background and has worked for the company since July 2010, will assume the role of Chief Financial Officer on an interim basis.
| 1st Jan change | Capi. | |
|---|---|---|
| -37.34% | 183M | |
| +9.83% | 118B | |
| +10.80% | 106B | |
| -10.84% | 23.4B | |
| -1.69% | 22.1B | |
| -10.23% | 18.34B | |
| -41.92% | 16.59B | |
| -15.11% | 15.97B | |
| +6.62% | 14.03B | |
| +17.53% | 11.67B |
FENNEC PHARMACEUTICALS INC. 
